Why Regulatory Clearance Doesn’t Guarantee Medical Device Reimbursement
Most MedTech companies design trials to clear the regulatory bar, only to find that payers need different evidence entirely. The result is a device that is approved but not covered, perhaps stalled between clearance and the market it was built to reach.
This infographic identifies the 7 reimbursement strategy gaps most likely to block adoption, explains what payers say when they encounter each one, and shows what a payer-ready study design looks like instead.
The 7 Gaps That Stall Devices Between Approval and Adoption
- Regulatory-only trial design
- Missing economic endpoints
- Weak comparator strategy
- Siloed planning
- No operational evidence
- Unclear value story
- Late reimbursement planning
Closing these gaps requires health economic evidence built into your study design from the start, rather than added after the submission is filed.
Download the infographic for the complete gap analysis, payer response examples, and a measurement guide covering devices, diagnostics, and SaMD.
Get the Full Framework
Fields marked with * are required.
